Product Code: TMRGL60987
The report provides revenue of the global hemorrhoid treatment devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemorrhoid treatment devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hemorrhoid treatment devices market.
The report delves into the competitive landscape of the global hemorrhoid treatment devices market. Key players operating in the global hemorrhoid treatment devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hemorrhoid treatment devices market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemorrhoid Treatment Devices Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, 2017 - 2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Regulatory Scenario Assessment
- 5.2. Technological Advancements
- 5.3. Pricing Analysis
- 5.4. COVID-19 Impact on Industry
6. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, By Device
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast By Device, 2017 - 2031
- 6.3.1. Band Ligators
- 6.3.1.1. Endoscopic Ligators
- 6.3.1.2. Non-endoscopic Ligators
- 6.3.2. Sclerotherapy Injectors
- 6.3.3. Infrared Coagulators
- 6.3.4. Bipolar Probes
- 6.3.5. Cryotherapy Devices
- 6.3.6. Hemorrhoid Laser Probes
- 6.3.7. Others
- 6.4. Market Attractiveness By Device
7. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, By End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast By End-user, 2017 - 2031
- 7.3.1. Hospitals & Clinics
- 7.3.2. Ambulatory Surgical Centers
- 7.3.3. Others
- 7.4. Market Attractiveness By End-user
8. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, By Region
- 8.1. Key Findings
- 8.2. Market Value Forecast By Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness By Country/Region
9. North America Hemorrhoid Treatment Devices Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value Forecast By Device, 2017 - 2031
- 9.2.1. Band Ligators
- 9.2.1.1. Endoscopic Ligators
- 9.2.1.2. Non-endoscopic Ligators
- 9.2.2. Sclerotherapy Injectors
- 9.2.3. Infrared Coagulators
- 9.2.4. Bipolar Probes
- 9.2.5. Cryotherapy Devices
- 9.2.6. Hemorrhoid Laser Probes
- 9.2.7. Others
- 9.3. Market Value Forecast By End-user, 2017 - 2031
- 9.3.1. Hospitals & Clinics
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Others
- 9.4. Market Value Forecast By Country, 2017 - 2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Device
- 9.5.2. By End-user
- 9.5.3. By Country
10. Europe Hemorrhoid Treatment Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast By Device, 2017 - 2031
- 10.2.1. Band Ligators
- 10.2.1.1. Endoscopic Ligators
- 10.2.1.2. Non-endoscopic Ligators
- 10.2.2. Sclerotherapy Injectors
- 10.2.3. Infrared Coagulators
- 10.2.4. Bipolar Probes
- 10.2.5. Cryotherapy Devices
- 10.2.6. Hemorrhoid Laser Probes
- 10.2.7. Others
- 10.3. Market Value Forecast By End-user, 2017 - 2031
- 10.3.1. Hospitals & Clinics
- 10.3.2. Ambulatory Surgical Centers
- 10.3.3. Others
- 10.4. Market Value Forecast By Country, 2017 - 2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Device
- 10.5.2. By End-user
- 10.5.3. By Country
11. Asia Pacific Hemorrhoid Treatment Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast By Device, 2017 - 2031
- 11.2.1. Band Ligators
- 11.2.1.1. Endoscopic Ligators
- 11.2.1.2. Non-endoscopic Ligators
- 11.2.2. Sclerotherapy Injectors
- 11.2.3. Infrared Coagulators
- 11.2.4. Bipolar Probes
- 11.2.5. Cryotherapy Devices
- 11.2.6. Hemorrhoid Laser Probes
- 11.2.7. Others
- 11.3. Market Value Forecast By End-user, 2017 - 2031
- 11.3.1. Hospitals & Clinics
- 11.3.2. Ambulatory Surgical Centers
- 11.3.3. Others
- 11.4. Market Value Forecast By Country, 2017 - 2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Device
- 11.5.2. By End-user
- 11.5.3. By Country
12. Latin America Hemorrhoid Treatment Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast By Device, 2017 - 2031
- 12.2.1. Band Ligators
- 12.2.1.1. Endoscopic Ligators
- 12.2.1.2. Non-endoscopic Ligators
- 12.2.2. Sclerotherapy Injectors
- 12.2.3. Infrared Coagulators
- 12.2.4. Bipolar Probes
- 12.2.5. Cryotherapy Devices
- 12.2.6. Hemorrhoid Laser Probes
- 12.2.7. Others
- 12.3. Market Value Forecast By End-user, 2017 - 2031
- 12.3.1. Hospitals & Clinics
- 12.3.2. Ambulatory Surgical Centers
- 12.3.3. Others
- 12.4. Market Value Forecast By Country, 2017 - 2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Device
- 12.5.2. By End-user
- 12.5.3. By Country
13. Middle East & Africa Hemorrhoid Treatment Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast By Device, 2017 - 2031
- 13.2.1. Band Ligators
- 13.2.1.1. Endoscopic Ligators
- 13.2.1.2. Non-endoscopic Ligators
- 13.2.2. Sclerotherapy Injectors
- 13.2.3. Infrared Coagulators
- 13.2.4. Bipolar Probes
- 13.2.5. Cryotherapy Devices
- 13.2.6. Hemorrhoid Laser Probes
- 13.2.7. Others
- 13.3. Market Value Forecast By End-user, 2017 - 2031
- 13.3.1. Hospitals & Clinics
- 13.3.2. Ambulatory Surgical Centers
- 13.3.3. Others
- 13.4. Market Value Forecast By Country, 2017 - 2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Device
- 13.5.2. By End-user
- 13.5.3. By Country
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 14.2. Market Share Analysis By Company (2021)
- 14.3. Company Profiles
- 14.3.1. Boston Scientific Corporation
- 14.3.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.1.2. Financial Overview
- 14.3.1.3. SWOT Analysis
- 14.3.1.4. Strategic Overview
- 14.3.2. Cook Medical
- 14.3.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.2.2. Financial Overview
- 14.3.2.3. SWOT Analysis
- 14.3.2.4. Strategic Overview
- 14.3.3. Medtronic Plc
- 14.3.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.3.2. Financial Overview
- 14.3.3.3. SWOT Analysis
- 14.3.3.4. Strategic Overview
- 14.3.4. Integra LifeSciences
- 14.3.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.4.2. Financial Overview
- 14.3.4.3. SWOT Analysis
- 14.3.4.4. Strategic Overview
- 14.3.5. CONMED Corporation
- 14.3.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.5.2. Financial Overview
- 14.3.5.3. SWOT Analysis
- 14.3.5.4. Strategic Overview
- 14.3.6. Sklar Surgical Instruments
- 14.3.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.6.2. Financial Overview
- 14.3.6.3. SWOT Analysis
- 14.3.6.4. Strategic Overview
- 14.3.7. Privi Medical (Tracxn Technologies Limited)
- 14.3.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
- 14.3.7.2. Financial Overview
- 14.3.7.3. SWOT Analysis
- 14.3.7.4. Strategic Overview